Benjamin Kim
InvestorPartner at Playground Global
Palo Alto, CA
Writes $1M β $20M checks Β· typically $10M
About
Benjamin Kim, PhD, is a Partner at Playground Global focused on engineered biology, emerging modality therapeutics, and applying AI/ML to drug development. He joined the firm as a Venture Fellow in 2019 while completing a PhD in bioengineering at Stanford University, where he was a National Science Foundation Fellow and published research in bioengineering, protein engineering, and chemical synthesis, and rose to Venture Principal in 2022 before his promotion to Partner.
ContactΒ· published on Benjamin's own website
Invests in
AI & Machine LearningBiotechDeep TechHardwareRoboticsSemiconductors
Experience
- Playground GlobalPartnercurrent2023 β presentPalo Alto, California, United States
- Playground GlobalVenture Principal2022 β 2023
- Playground GlobalSenior Venture Associate2022
- Playground GlobalVenture Associate2020 β 2021
- InsamoBoard Observer + Lead Series Seed Investorcurrent2024 β presentSan Francisco Bay Area
- Amber BioBoard Observer + Lead Series Seed Investorcurrent2023 β presentSan Francisco, California, United States
- Atomic AIBoard Observer + Lead Series A Investorcurrent2022 β presentSan Francisco Bay Area
- InfinimmuneBoard Director + Lead Series Seed Investorcurrent2022 β presentSan Francisco Bay Area
- Outpace BioLead Series A/A1 Investorcurrent2021 β presentSeattle, Washington, United States
- Manifold BioBoard Observer + Lead Series Seed Investorcurrent2020 β presentBoston, Massachusetts, United States
- Lassogen, Inc.Board Observer + Lead Series Seed Investorcurrent2020 β presentSan Diego, California, United States
- Stanford UniversityPhD Graduate Student2013 β 2019United States
- Merck KGaA, Darmstadt, GermanyInnovation Team Leader2018
Deals Β· 2
InsamoLed round
via Playground Global Β· filed Dec 2023
Manifold BioLed round
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Amber BioAtomic AIInfinimmuneOutpace Bio
Board seats
InfinimmuneOutpace BioSynthetic Design Labs
Investor
Per the firm's website.
Colleagues at Playground Global
Network2
Investors connected to Benjamin in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Benjamin Kim?
- Benjamin Kim, PhD, is a Partner at Playground Global focused on engineered biology, emerging modality therapeutics, and applying AI/ML to drug development. He joined the firm as a Venture Fellow in 2019 while completing a PhD in bioengineering at Stanford University, where he was a National Science Foundation Fellow and published research in bioengineering, protein engineering, and chemical synthesis, and rose to Venture Principal in 2022 before his promotion to Partner.
- Where does Benjamin Kim work?
- Benjamin Kim is Partner at Playground Global.
- What does Benjamin Kim invest in?
- Benjamin Kim invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Robotics, Semiconductors.
- What check size does Benjamin Kim write?
- Benjamin Kim typically writes checks of $1M β $20M.
- What boards does Benjamin Kim sit on?
- Benjamin Kim holds tracked board seats at Infinimmune, Manifold Bio, Outpace Bio, Synthetic Design Labs.
- What companies has Benjamin Kim invested in?
- Investments tracked here include Amber Bio, Atomic AI, Infinimmune, Insamo, Manifold Bio, Outpace Bio, Outpace Bio.
- Where did Benjamin Kim go to school?
- Benjamin Kim studied at Stanford University (Doctor of Philosophy (PhD), Bioengineering and Biomedical Engineering); Stanford University (Master of Science (MS), Bioengineering and Biomedical Engineering); Washington University in St. Louis (B.A, Biochemistry).
- Does Benjamin Kim lead rounds?
- Yes β Benjamin Kim has led 6 tracked investments.
Same school
Also attended Stanford University2,000
+ 1,994 more
Also attended Washington University in St. Louis220
+ 214 more
Shared employers
Also worked at Playground Global44
+ 38 more












.jpg)


























